Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PIK3CA mutations in ovarian cancer.

× No keyword cloud information.

5 in total

1. PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.

Authors: Hong-Guang Li; Fang-Feng Liu; Hua-Qiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jin-Hua Hu
Journal: Int J Clin Exp Pathol Date: 2015-11-01

2. Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines.

Authors: Ji Eun Kim; Clare Stones; Wayne R Joseph; Euphemia Leung; Graeme J Finlay; Andrew N Shelling; Wayne A Phillips; Peter R Shepherd; Bruce C Baguley
Journal: BMC Cancer Date: 2012-04-04 Impact factor: 4.430

3. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.

Authors: Chi Hoon Maeng; Jeeyun Lee; Paul van Hummelen; Se Hoon Park; Emanuele Palescandolo; Jiryeon Jang; Ha Young Park; So Young Kang; Laura MacConaill; Kyoung-Mee Kim; Young-Mog Shim
Journal: PLoS One Date: 2012-08-03 Impact factor: 3.240

4. Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells.

Authors: Ji-Hong Song; Cheol-Jung Lee; Hyun-Jung An; Sun-Mi Yoo; Han C Kang; Joo Y Lee; Kwang D Kim; Dae J Kim; Hye S Lee; Yong-Yeon Cho
Journal: Mol Carcinog Date: 2018-09-21 Impact factor: 4.784

5. Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.

Authors: Anne L Estep; Chana Palmer; Frank McCormick; Katherine A Rauen
Journal: PLoS One Date: 2007-12-05 Impact factor: 3.240

5 in total